BioPharma Dive11h
Galapagos, after research struggles, will split in two and revamp Gilead deal
Alongside plans to spin out a new company, the Belgian drugmaker said it will cut some 300 positions, or about 40% of its ...
BioPharma Dive20h
FDA adds warning to RSV shots from GSK, Pfizer
Barré syndrome, although it said data don’t prove a causal link and affirmed the shots’ benefit outweighs their risks.
BioPharma Dive21h
Bioanalytical CRO, Veloxity Labs, Announces 50% Year-Over-Year Growth in 2024, Expands Operations to Meet Rising Demand
Peoria, IL, Jan 8, 2025 — Veloxity Labs, a bioanalytical contract research organization (CRO) specializing in accelerating ...
BioPharma Dive21h
Kidney disease drugmaker Maze files for IPO
Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised ...
BioPharma Dive21h
Tenvie raises $200M for brain drug R&D; Sana spikes on single patient’s results
The Arch-backed startup begins life with several assets acquired from Denali Therapeutics. Elsewhere, Jasper got a negative ...
BioPharma Dive23h
Bioforum Announces Formation of Board of Directors and New Members Bryan Katz and Calvin Liou
January 7th, 2025 – Bioforum, The Data Masters, a leading global clinical research organization (CRO) specializing in ...